---
$id: https://graph.org.ai/products/commodity/51101938
$type: Product
source: UNSPSC
code: "51101938"
title: "Tebuquine"
class: "51101900"
classTitle: "Antiprotozoals"
family: "51100000"
familyTitle: "Amebicides and trichomonacides and antiprotozoals"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Tebuquine

**UNSPSC Code**: 51101938
**Class**: [Antiprotozoals](Antiprotozoals.mdx)
**Family**: [Amebicides and trichomonacides and antiprotozoals](../Amebicides and trichomonacides and antiprotozoals.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antimalarial agent with the molecular formula C26H25Cl2N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 699Q1XT4EN, chemically known as wr 228,258 but generally known as tebuquine, which bears US NIH Compound Identifier 71991. European Medicines Agency schedules Tebuquine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10855MIG. The term TEBUQUINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). TEBUQUINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tebuquine under HS 29334990 and SITC 51575. As of Q4 2014, TEBUQUINE remains the US FDA Preferred Term for this commodity. Tebuquine bears US NLM identifiers UMLS ID C0144939 and NCI Concept Code C75270. SMILES: CLC1CCC(C2C(O)C(CNC(C)(C)C)CC(NC3C4C(NCC3)CC(CL)CC4)C2)CC1.

